Inhaled Nitric Oxide Delivery Systems Market Size, Share & Trends Analysis Report By Type (Pediatric, Adult), By Application (HRF, AHRF), By Product (Disposables, Systems), By End Use- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Product Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Inhaled Nitric Oxide Delivery Systems Market, By Type

7.1.  Inhaled Nitric Oxide Delivery Systems Market, by Type, 2021-2027

7.1.1.    Pediatrics

7.1.1.1.        Market Revenue and Forecast (2017-2027)

7.1.2.    Adult

7.1.2.1.        Market Revenue and Forecast (2017-2027)

Chapter 8.  Global Inhaled Nitric Oxide Delivery Systems Market, By Application

8.1.  Inhaled Nitric Oxide Delivery Systems Market, by Application, 2021-2027

8.1.1.    Hypoxic Respiratory Failure (HRF)

8.1.1.1.        Market Revenue and Forecast (2017-2027)

8.1.2.    Acute Hypoxemic Respiratory Failure (AHRF)

8.1.2.1.        Market Revenue and Forecast (2017-2027)

8.1.3.    Others

8.1.3.1.        Market Revenue and Forecast (2017-2027)

Chapter 9.  Global Inhaled Nitric Oxide Delivery Systems Market, By Product

9.1.  Inhaled Nitric Oxide Delivery Systems Market, by Product, 2021-2027

9.1.1.    Disposables

9.1.1.1.        Market Revenue and Forecast (2017-2027)

9.1.2.    System

9.1.2.1.        Market Revenue and Forecast (2017-2027)

Chapter 10.      Global Inhaled Nitric Oxide Delivery Systems Market, By End-user

10.1.        Inhaled Nitric Oxide Delivery Systems Market, by End-user, 2021-2027

10.1.1.  Hospitals

10.1.1.1.      Market Revenue and Forecast (2017-2027)

10.1.2.  Ambulatory Centers

10.1.2.1.      Market Revenue and Forecast (2017-2027)

10.1.3.  Clinics

10.1.3.1.      Market Revenue and Forecast (2017-2027)

Chapter 11.      Global Inhaled Nitric Oxide Delivery Systems Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Type (2017-2027)

11.1.2.  Market Revenue and Forecast, by Application (2017-2027)

11.1.3.  Market Revenue and Forecast, by Product (2017-2027)

11.1.4.  Market Revenue and Forecast, by End-user (2017-2027)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Type (2017-2027)

11.1.5.2.      Market Revenue and Forecast, by Application (2017-2027)

11.1.5.3.      Market Revenue and Forecast, by Product (2017-2027)

11.1.5.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Type (2017-2027)

11.1.6.2.      Market Revenue and Forecast, by Application (2017-2027)

11.1.6.3.      Market Revenue and Forecast, by Product (2017-2027)

11.1.6.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Type (2017-2027)

11.2.2.  Market Revenue and Forecast, by Application (2017-2027)

11.2.3.  Market Revenue and Forecast, by Product (2017-2027)

11.2.4.  Market Revenue and Forecast, by End-user (2017-2027)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Type (2017-2027)

11.2.5.2.      Market Revenue and Forecast, by Application (2017-2027)

11.2.5.3.      Market Revenue and Forecast, by Product (2017-2027)

11.2.5.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Type (2017-2027)

11.2.6.2.      Market Revenue and Forecast, by Application (2017-2027)

11.2.6.3.      Market Revenue and Forecast, by Product (2017-2027)

11.2.6.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Type (2017-2027)

11.2.7.2.      Market Revenue and Forecast, by Application (2017-2027)

11.2.7.3.      Market Revenue and Forecast, by Product (2017-2027)

11.2.7.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Type (2017-2027)

11.2.8.2.      Market Revenue and Forecast, by Application (2017-2027)

11.2.8.3.      Market Revenue and Forecast, by Product (2017-2027)

11.2.8.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Type (2017-2027)

11.3.2.  Market Revenue and Forecast, by Application (2017-2027)

11.3.3.  Market Revenue and Forecast, by Product (2017-2027)

11.3.4.  Market Revenue and Forecast, by End-user (2017-2027)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Type (2017-2027)

11.3.5.2.      Market Revenue and Forecast, by Application (2017-2027)

11.3.5.3.      Market Revenue and Forecast, by Product (2017-2027)

11.3.5.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Type (2017-2027)

11.3.6.2.      Market Revenue and Forecast, by Application (2017-2027)

11.3.6.3.      Market Revenue and Forecast, by Product (2017-2027)

11.3.6.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Type (2017-2027)

11.3.7.2.      Market Revenue and Forecast, by Application (2017-2027)

11.3.7.3.      Market Revenue and Forecast, by Product (2017-2027)

11.3.7.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Type (2017-2027)

11.3.8.2.      Market Revenue and Forecast, by Application (2017-2027)

11.3.8.3.      Market Revenue and Forecast, by Product (2017-2027)

11.3.8.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Type (2017-2027)

11.4.2.  Market Revenue and Forecast, by Application (2017-2027)

11.4.3.  Market Revenue and Forecast, by Product (2017-2027)

11.4.4.  Market Revenue and Forecast, by End-user (2017-2027)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Type (2017-2027)

11.4.5.2.      Market Revenue and Forecast, by Application (2017-2027)

11.4.5.3.      Market Revenue and Forecast, by Product (2017-2027)

11.4.5.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Type (2017-2027)

11.4.6.2.      Market Revenue and Forecast, by Application (2017-2027)

11.4.6.3.      Market Revenue and Forecast, by Product (2017-2027)

11.4.6.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Type (2017-2027)

11.4.7.2.      Market Revenue and Forecast, by Application (2017-2027)

11.4.7.3.      Market Revenue and Forecast, by Product (2017-2027)

11.4.7.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Type (2017-2027)

11.4.8.2.      Market Revenue and Forecast, by Application (2017-2027)

11.4.8.3.      Market Revenue and Forecast, by Product (2017-2027)

11.4.8.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Type (2017-2027)

11.5.2.  Market Revenue and Forecast, by Application (2017-2027)

11.5.3.  Market Revenue and Forecast, by Product (2017-2027)

11.5.4.  Market Revenue and Forecast, by End-user (2017-2027)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Type (2017-2027)

11.5.5.2.      Market Revenue and Forecast, by Application (2017-2027)

11.5.5.3.      Market Revenue and Forecast, by Product (2017-2027)

11.5.5.4.      Market Revenue and Forecast, by End-user (2017-2027)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Type (2017-2027)

11.5.6.2.      Market Revenue and Forecast, by Application (2017-2027)

11.5.6.3.      Market Revenue and Forecast, by Product (2017-2027)

11.5.6.4.      Market Revenue and Forecast, by End-user (2017-2027)

Chapter 12.  Company Profiles

12.1.              Mallinckrodt Pharmaceuticals

12.1.1.  Company Overview

12.1.2.  Type Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Getinge

12.2.1.  Company Overview

12.2.2.  Type Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Vero Biotech

12.3.1.  Company Overview

12.3.2.  Type Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              LINDE

12.4.1.  Company Overview

12.4.2.  Type Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Beyond Air

12.5.1.  Company Overview

12.5.2.  Type Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              SLE

12.6.1.  Company Overview

12.6.2.  Type Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              NU MED

12.7.1.  Company Overview

12.7.2.  Type Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Bellerophon Therapeutics

12.8.1.  Company Overview

12.8.2.  Type Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Air Liquide Healthcare

12.9.1.  Company Overview

12.9.2.  Type Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Circassia Pharmaceuticals

12.10.1.               Company Overview

12.10.2.               Type Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms